Source comparison
BPC-157 vs GHK-Cu: Research Protocol Comparison
Primary Mechanism VEGF upregulation, angiogenesis, FAK-paxillin pathway activation Gene transcription modulation, MMP/TIMP regulation, copper-dependent collagen cross-linking BPC-157 for vascular phase; GHK-Cu for remodeling phase Optimal Tissue Targets Tendon
This comparison does not assign a generated winner or score.
- Primary Mechanism
- VEGF upregulation, angiogenesis, FAK-paxillin pathway activation
- Gene transcription modulation, MMP/TIMP regulation, copper-dependent collagen cross-linking
- BPC-157 for vascular phase; GHK-Cu for remodeling phase
- Optimal Tissue Targets
- Tendon, ligament, GI mucosa, muscle (highly vascularized)
- Skin, bone matrix, nerve, chronic wounds (collagen-dependent)
- Match peptide to dominant tissue repair phase in your model
- Typical Dosing Range (research models)
- 200–500 mcg/kg/day (rat models); human equivalent ~10–20 mcg/kg/day
- 1–3 mg/kg applied topically or 0.5–1.0 mg/kg systemically
- BPC-157 dosed daily; GHK-Cu effective even with every-other-day protocols
- Timeline to Measurable Effects
- 7–14 days (angiogenesis markers, wound closure rate)
- 21–42 days (collagen deposition, MMP activity, scar tensile strength)
- Shorter studies favor BPC-157; long-term studies favor GHK-Cu
- Stability & Storage
- Stable as lyophilized powder at -20°C; reconstituted solution stable 28 days at 2–8°C
- Copper complex requires protection from light; stable lyophilized at -20°C; reconstituted stable 14–21 days refrigerated
- Both require bacteriostatic water reconstitution; GHK-Cu more light-sensitive
- Cost Per Study (approximate)
- $180–$320 for 30-day rodent study (based on 10 subjects at 300 mcg/kg/day)
- $240–$450 for 60-day rodent study (based on 10 subjects at 1 mg/kg topical application)
- Longer GHK-Cu timelines increase overall study cost despite similar per-dose pricing
- Bottom Line
- Best for acute injury models, vascular repair studies, short-duration protocols measuring early healing markers
- Best for chronic inflammation models, matrix remodeling studies, long-duration protocols measuring collagen quality and scar maturation
- Not interchangeable—mechanism must match research question
- The stability difference is more significant than most researchers realize. BPC-157 remains biologically active in acidic environments (pH 2.0–3.0) due to its gastric origin, making it suitable for oral administration studies in addition to injection protocols. GHK-Cu's copper complex is pH-sensitive and degrades rapidly below pH 5.0, limiting it to topical, subcutaneous, or intravenous routes in most research designs.